首页> 外文期刊>The journal of clinical endocrinology and metabolism >Minireview: β-cell Replacement Therapy for Diabetes in the Twenty-First Century: Manipulation of Cell Fate by Directed Differentiation
【24h】

Minireview: β-cell Replacement Therapy for Diabetes in the Twenty-First Century: Manipulation of Cell Fate by Directed Differentiation

机译:Minireview:二十一世纪糖尿病的β细胞替代疗法:通过定向分化操纵细胞命运

获取原文
       

摘要

Theorphannuclearreceptorsteroidogenicfactor1(SF-1,alsocalledAd4BP,encodedbytheNR5A1gene)isanessentialregulatorofendocrinedevelopmentandfunction.Initiallyidentifiedasatissue-specifictranscriptionalregulatorofcytochromeP450steroidhydroxylases, studies of both global and tissue-specific knockout mice have demonstrated that SF-1 is required for the develop-ment of the adrenal glands, gonads and ventromedial hypothalamus and for the proper functioning of pituitary gonadotropes.ManygenesaretranscriptionallyregulatedbySF-1,andmanyproteinsinturninteractwithSF-1andmodulateitsactivity.Whereasmice with heterozygous mutations that disrupt SF-1 function have only subtle abnormalities, humans with heterozygous SF-1mutations can present with XY sex reversal (i.e., testicular failure), ovarian failure and occasionally adrenal insufficiency; dys-regulationofSF-1hasbeenlinkedtodiseasessuchasendometriosisandadrenocorticalcarcinoma.ThecurrentstateofknowledgeofthisimportanttranscriptionfactorwillbereviewedwithaparticularemphasisonthepioneeringworkonSF-2bythelateKeithParker.
机译:孤儿核受体类固醇生成因子1(SF-1,也称为Ad4BP,由NR5A1基因编码)是内分泌发育和功能的重要调节剂。最初鉴定为细胞色素P450类固醇羟化酶的组织特异性转录调节剂,对整体小鼠和组织特异性敲除小鼠的研究均表明,SF-1促进了腺体和肾上腺的发育,并需要SF-1促进肾上腺和肾上腺的发育垂体促性腺激素的正常功能。许多基因受SF-1转录调控,许多蛋白又与SF-1相互作用并调节其活性。杂合突变破坏SF-1功能的小鼠只有细微的异常,而杂合SF-1突变的人类可出现XY性逆转(即睾丸性)失败,有时肾上腺功能不全; SF-1的失调与诸如子宫内膜异位症和肾上腺皮质癌等疾病有关。通过Keith Parker的研究,SF-1的这一重要转录因子的当前状态将特别受到SF-2开拓性研究的关注。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号